Synedgen Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 24

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 5

Synedgen General Information

Description

Developer of polysaccharide-based drugs designed to enhance and mimic the innate immune system. The company's drugs target the complex interactions at the cell surface and mucosal interface to suppress inflammation, reduce infection, and improve healing at surfaces, enabling physicians to deliver improved quality of life for their patients with diseases of the gastrointestinal tract and pulmonary tree.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1420 North Claremont Boulevard
  • Suite 105 D
  • Claremont, CA 91711
  • United States
+1 (909)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 1420 North Claremont Boulevard
  • Suite 105 D
  • Claremont, CA 91711
  • United States
+1 (909)

Synedgen Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Synedgen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
17. Later Stage VC 01-Jul-2026 Completed Generating Revenue
16. Secondary Transaction - Private 01-Jun-2026 Completed Generating Revenue
15. Debt - General 01-Oct-2024 Completed Generating Revenue
14. Grant 17-Oct-2021 Completed Generating Revenue
13. Debt - PPP 28-Apr-2020 Completed Generating Revenue
12. Later Stage VC 29-Jan-2020 Completed Generating Revenue
11. Grant 13-Dec-2019 Completed Generating Revenue
10. Grant 30-Sep-2019 Completed Generating Revenue
9. Later Stage VC 11-Sep-2017 $6M $23.1M Completed Generating Revenue
8. Debt - General 07-Nov-2016 $3M $17.1M Completed Generating Revenue
To view Synedgen’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Synedgen Patents

Synedgen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2025232101-A1 Compositions and methods of their use Pending 08-Mar-2024
WO-2025189143-A1 Compositions and methods of their use Pending 08-Mar-2024
WO-2025189143-A8 Compositions and methods of their use Pending 08-Mar-2024
AU-2020444897-A1 Compositions and methods of use thereof Pending 30-Apr-2020
EP-4142740-A1 Compositions and methods of use thereof Pending 30-Apr-2020 A61K31/726
To view Synedgen’s complete patent history, request access »

Synedgen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Synedgen Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
HMC INQ Venture Capital Minority
StoryHouse Ventures Venture Capital Minority
United States Army Medical Research Acquisition Activity (USAMRAA) Government
National Institutes of Health Government
United States Department of War Government
To view Synedgen’s complete investors history, request access »

Synedgen FAQs

  • When was Synedgen founded?

    Synedgen was founded in 2009.

  • Where is Synedgen headquartered?

    Synedgen is headquartered in Claremont, CA.

  • What is the size of Synedgen?

    Synedgen has 24 total employees.

  • What industry is Synedgen in?

    Synedgen’s primary industry is Drug Discovery.

  • Is Synedgen a private or public company?

    Synedgen is a Private company.

  • What is Synedgen’s current revenue?

    The current revenue for Synedgen is .

  • How much funding has Synedgen raised over time?

    Synedgen has raised $27.4M.

  • Who are Synedgen’s investors?

    HMC INQ, StoryHouse Ventures, United States Army Medical Research Acquisition Activity (USAMRAA), National Institutes of Health, and United States Department of War have invested in Synedgen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process